• network 13 home
  • providers
  • patients
  • FDA Medwatch
  • Facility Resource Materials
  • Other Resources
  • Dialysis Facility Compare
  • Disaster Readiness
  • Educational Library
  • Upcoming Events
  • Professional Newsletter
  • Quality Improvement
  • Data
    • Forms
    • CROWNWeb
  • Patient Services
    • Patient Advocacy Committee
    • Kidney Community Gatherings
    • Network Patient Representative Program
    • Patient Rights & Responsibilities
    • Returning to Work (Vocational Rehabilitation)
    • Complaints and Grievance Page
    • Involuntary Discharge Requirements
  • Medicare ESRD Information
  • Reports
    • Annual Report
    • DFR/QIP
    • QI Reports
    • Demographics
    • National Survey Summary
  • Patient Services Tools
  • WebEx Seminars
  • Contact Us

ESRD Network 13 Medwatch Database

To Search the ESRD Network 13 FDA Medwatch Database click here.

ESRD's FDA Medwatch Listing
06/17/2013 FDA MedWatch - Cybersecurity for Medical Devices and Hospital Networks: FDA Safety Communication
06/14/2013 FDA MedWatch - May 2013 Safety Labeling Changes includes 40 products with revisions to Prescribing Information
05/29/2013 FDA MedWatch - Main Street Family Pharmacy in Tennessee: FDA Alerts Health Care Providers of Adverse Reactions Associated with Steroid Injections - Update
05/20/2013 FDA MedWatch - All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance
05/20/2013 FDA MedWatch - Abbott Diabetes Care: Class 1 Recall - FreeStyle InsuLinx Blood Glucose Meters - Risk of Incorrect Test Result
05/17/2013 FDA MedWatch - Compounded Prescription Therapies By Pentec Health Inc.: Recall - Lack Of Sterility Assurance
05/16/2013 FDA MedWatch - April 2013 Safety Labeling Changes includes 48 products with revisions to Prescribing Information
05/09/2013 FDA MedWatch - The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products
05/01/2013 FDA MedWatch - Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) BLOOD-PACK Unit By Fenwal: Recall - Labeling Issue Identified
04/30/2013 FDA MedWatch - Piperacillin and Tazobactam for Injection, USP 40.5 grams: Recall - Precipitation or Crystallization in IV Bag or IV Line Upon Reconstitution
Next Last

 



Privacy Policy | Contact Us | Site Map

© 2013 FMQAI: ESRD Network 13. All rights reserved.
FMQAI: Network 13's Bylaws, Articles of Incorporation and Conflict of Interest Policy are available for review from the Network office.

This material was prepared by ESRD Network 13 under the Centers for Medicare & Medicaid Services (CMS) Contract Number HHSM-500-2010-NW013C. The contents presented do not necessarily reflect CMS policy, nor imply endorsement by the U.S. Government.